Home/ Supplements/ Melatonin/ Melatonin Sublingual 2.5 mg (2,500 mcg) ...

Melatonin Sublingual 2.5 mg (2,500 mcg) Fruit Flavored

product on market Tablet or Pill Wonder Laboratories Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 100% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · grounded in 1 source · methodology

Melatonin is supported by strong evidence for its role in regulating sleep-wake cycles and reducing sleep latency. Vitamin B6 serves as a cofactor in the synthesis of neurotransmitters that influence mood and sleep. Together, these ingredients target sleep support, though the overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Melatonin Sublingual 2.5 mg (2,500 mcg) Fruit Flavored
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Tablet(s)
Serving Size
60
Servings
Other Combinations
Product Type
100%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

0.5 mg (29% DV)
Within RDA (0.4× RDA) 114 studies (A:3, B:35)
2.5 mg
Market median: 3.0mg (984 products) 240 studies (A:2, B:109)

Other Ingredients

Dextrose Stearic Acid Magnesium Stearate Silica Orange crystals Orange Flavor
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Adults, allow one tablet to dissolve under tongue 20 minutes before bedtime.

Warnings & Precautions

Tamper evident: Do not use this product if imprinted foil seal under cap is broken or missing.

Keep out of reach of children.

Warning: This product is not to be taken by pregnant or lactating women, individuals with autoimmune conditions or depressive disorders, or children under 16 years of age.

Warning: This product is not to be taken by pregnant or lactating women, individuals with autoimmune conditions or depressive disorders, or children under 16 years of age.

Do not take this product when driving a motor vehicle or operating machinery.

Read warning section of label prior to taking product. Do not exceed two tablets in any 24 hour period.

Formulation Notes

Mfg. in an FDA Registered Facility using Good Manufacturing Practices (GMPs)

Conforms to USP <2091> for weight.

Nutritionally supports a healthy sleep pattern

Gluten free

Additional Information

Keep tightly closed. Store at room temperature 59 degrees - 86 degrees F (15 degrees - 30 degrees C).

Formula 256

Metadata

Product Details

UPC / SKU0 99528 25660 0
DSLD Entry Date2025-02-23
Product TypeOther Combinations
FormTablet or Pill
DSLD ID325868
Data Updated2026-04-11
Research

Research Evidence

291
Research Sources
55
Avg Quality
129
Meta Analysis
93
Systematic Review
51
Rct
11
Clinical Trial
2
Other
2
Regulatory Source
1
Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022 PubMed DOI
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022 PubMed DOI
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022 PubMed DOI
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023 PubMed DOI
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Melatonin →
Compare

Similar Products

View all Melatonin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.